Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
Status:
Completed
Trial end date:
2016-06-13
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the effect of oral eleclazine (formerly
GS-6615) on corrected QT (QTc) interval in participants with long QT2 syndrome.